Literature DB >> 8946305

Reliability of underlying incidence rates for estimating the effect and efficiency of screening for breast cancer.

P Prior1, C B Woodman, S Wilson, A G Threlfall.   

Abstract

The process of setting screening performance targets requires an estimate of what the incidence of breast cancer would have been in the population invited for screening if there had not been a screening programme. Before the introduction of the National Health Service breast screening programme in 1988 the incidence of breast cancer was already increasing in the population targeted for screening. To establish the incidence before screening the most recent complete data from all the regional cancer registries were collated. An age-period model was constructed to predict what these incidence rates might now have been if the screening programme had not been introduced. The model predicted that if prescreening trends continued (between 1987 and 1995) underlying incidence over this period would increase by 2.3 per 10,000 in women aged 50-54, 2.6 per 10,000 in women aged 55-59, and 2.9 per 10,000 in women aged 60-64. If the prescreening trends have continued then the use of a universal rate, applied across all calendar years and age groups, would seem to be inappropriate when setting targets.

Entities:  

Mesh:

Year:  1996        PMID: 8946305     DOI: 10.1177/096914139600300303

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  5 in total

1.  Risk of breast cancer in women who attend the NHS breast screening programme: cohort study.

Authors:  A G Threlfall; C B Woodman
Journal:  BMJ       Date:  2001-07-21

2.  Maximising benefit and minimising harm of screening.

Authors:  J A M Gray; J Patnick; R G Blanks
Journal:  BMJ       Date:  2008-03-01

3.  Calculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme. Interval Cancer Working Group.

Authors:  S Moss; R Blanks
Journal:  J Epidemiol Community Health       Date:  1998-02       Impact factor: 3.710

4.  Interval cancers in the Dutch breast cancer screening programme.

Authors:  J Fracheboud; H J de Koning; P M Beemsterboer; R Boer; A L Verbeek; J H Hendriks; B M van Ineveld; M J Broeders; A E de Bruyn; P J van der Maas
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

5.  Impact of NHS breast screening on advanced disease and mortality from breast cancer in the North West of England.

Authors:  A G Threlfall; S Collins; C B J Woodman
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.